Markets.com Logo

EGRX

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    3.1698$
  • Previous Close
    3.1698$
  • 52 Week Change
    5.45$
  • Day Range
    0.00$
  • 52 Week High/Low
    0.0025$ - 5.45$
  • Dividend Per Share
    --
  • Market cap
    41 337 K$
  • EPS
    0
  • Beta
    0.807
  • Volume
    --

About

EGRX.US represents Eagle Pharmaceuticals, Inc., a pharmaceutical company focused on developing and commercializing injectable products, primarily in the critical care and hospital setting. Their portfolio includes products like PEMFEXY (pemetrexed for injection), an alternative to Alimta, and BARHEMSYS (amisulpride injection), indicated for the prevention and treatment of postoperative nausea and vomiting. The company often utilizes the FDA's 505(b)(2) regulatory pathway to develop their products, a process that allows them to rely, in part, on the FDA's previous findings of safety and effectiveness for a previously approved product.

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

FactorName: Company-Specific News, such as clinical trial results for their drug candidates, regulatory approvals or rejections, partnerships, and financial performance reports, directly impact investor confidence and stock valuation.

FactorName: Broader Market Trends influence stock prices. Overall economic conditions, investor sentiment, and industry performance can create upward or downward pressure on EGRX even without specific news.

FactorName: Competition within the biotechnology sector, including the progress and success of rival companies developing similar drugs or therapies, impacts EGRX's market share and potential future revenue.

FactorName: Regulatory Landscape regarding drug development and approval, including changes in FDA policies or requirements, significantly affects the timeline, cost, and ultimate success of EGRX's products.

FactorName: Funding and Cash Flow, including the company's ability to raise capital through stock offerings or debt financing, impacts investor perceptions of its financial stability and ability to fund research and development.

People Also Watch

Latest news

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation

Ava Grace|--

US Intelligence: Iran Unwilling to Engage in Substantive Talks to End War

Sophia Claire|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--